Vecchiet L, Di Lisa F, et al
GLP-1 receptor agonists are large protein molecules exceeding 3,000 Daltons in molecular weight, far above the 500 Dalton threshold for effective passive skin penetration
The definitive impact of tirzepatide on cardiovascular disease will be addressed in the ongoing SURPASS-COVT study (ClinicalTrials.gov number, NCT04255433), which compares tirzepatide with dulaglutide in patients with T2DM and ASCVD
Because tirzepatide targets two incretin receptors rather than one, its weight loss trajectory tends to be steeper initially, with greater total weight loss over time compared to semaglutide monotherapy
At the end of the permeability assay midbrain organoids were removed from the bottom of acceptor compartments, homogenized in DW containing Triton X-100 (10 mg/ml)
Stick to the 28-day storage limit to minimize this risk